Fresenius Medical Care | FME - Ebitda

Aktienkurs
37.37
Täglich Wechseln
0.38 1.03%
Monatlich
-4.06%
Jährlich
-27.30%
Q2 Prognose
36.39




Ebitda Veränderung Datum
Akzo Nobel EUR 345M 540M 2026-03
Alcon AG USD 795M 478M 2026-03
AstraZeneca USD 5.67B 1.29B 2026-03
Bayer EUR 4.45B 2.49B 2026-03
Beiersdorf EUR 984M 147M 2025-06
DaVita Healthcare Partners USD 659.83M 112.87M 2026-03
Demant DKK 2.76B 165M 2025-12
E.ON EUR 2.83B 1.05B 2025-12
Essilor EUR 3.09B 356M 2024-12
Fresenius EUR 951M 283M 2026-03
Fresenius Medical Care EUR 824M 250M 2026-03
Genmab DKK 186M 291M 2025-12
Getinge SEK 3.47B 2.13B 2024-12
Givaudan CHF 778M 195M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GN Store Nord DKK 491M 136M 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.44B 263M 2025-12
Novartis USD 5.3B 530M 2026-03
Philips EUR 567M 233M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
RWE EUR 1.63B 20M 2026-03
Sanofi EUR 3.31B 3.65B 2026-03
SAP EUR 3.17B 606M 2026-03
Smith & Nephew USD 796M 139M 2025-12